Navigation Links
Joint Statement On The President's Budget From The American Society Of Clinical Oncology, Community Oncology Alliance, ION Solutions and The US Oncology Network
Date:4/12/2013

WASHINGTON, April 12, 2013 /PRNewswire-USNewswire/ -- The President has released his proposed budget for fiscal year 2014, which proposes new reductions for cancer care services.  Taken in combination with existing strains imposed by sequestration, this proposal threatens access to care for some of America's most vulnerable:  elderly patients with cancer.  In addition to reduced payments for cancer fighting drugs, the Administration has proposed new limitations on imaging technology used to diagnose and manage cancer.  Cast by the President as strategies for improving long term solvency of the Medicare program, these proposed policies will, instead, have the effect of increasing cost to the Administration.  By straining community oncology clinics to their breaking point, the Medicare program will push practices to either limit Medicare services or close their doors altogether. That will send patients to more expensive settings for treatment.  Over the past two weeks, our organizations have urged Congress and the Administration to reverse the cut to cancer drugs imposed by sequestration and we object in the strongest possible terms to any proposal that would add to the existing crisis.

The President's budget proposes to cut Medicare reimbursement from Average Sales Price (ASP) of cancer drugs plus the 6 percent facilities/operations services fee to ASP plus 3 percent.  As it is, the Medicare payment rate for drugs set at ASP plus 6 percent is in actuality closer to a total of ASP plus 2 percent because Medicare's payment formula includes prompt pay discounts manufacturers provide to drug wholesalers but which are not available to cancer clinics.  Added to that is the fact that many patients without secondary insurance often cannot afford copayment for increasingly expensive anti-cancer drugs, a problem that has increased the burden of bad debt for many practices.  As a result, even at ASP plus 6 percent, many cancer drugs are reimbursed by Medicare at less than their total costs of acquisition, storage, and handling.

Most disconcerting about the President's proposed budget cut to cancer drugs, is that the Administration has already chosen to cut payment by applying the Medicare sequester cut to the underlying cost of cancer drugs.  The Centers for Medicare & Medicaid Services (CMS) has questionable statutory authority to cut the Medicare reimbursement rate specifically fixed in law[1] and has ignored flexibility guidance by the Office of Management and Budget (OMB) in implementing sequestration[2].  As a result, as of April 1, 2013, CMS is paying for cancer drugs at the rate of ASP plus 4.3 percent.

The unnecessary sequester cut to cancer drugs is already having an impact on the cancer care of seniors.  It has forced community cancer clinics into emergency mode, with many clinics now being forced to send certain Medicare patients elsewhere for treatment.  This will increase in scope and severity as the full impact of the sequester cut is realized.  It is disconcerting that the Administration is ignoring this crisis, and now threatens to accelerate it with a proposed deeper payment cut to cancer drugs. 

Flawed Medicare payment for cancer drugs has already markedly consolidated cancer care delivery.  Until recently, more than 80 percent of the nation's cancer patients were treated in physicians' offices in the community setting. Since 2008, more than 1,200 community cancer care centers have closed, consolidated, or reported financial problems.[3]  When community cancer clinics close their doors, access to cancer care is compromised for all cancer patients, but especially vulnerable seniors.  Studies by Milliman[4] and Avalere[5] document that consolidation of care results in higher costs of cancer treatment for Medicare, seniors, and all taxpayers. 

We are also concerned that the President's budget could severely impede the essential cancer-fighting services provided by integrated community cancer clinics.  The Administration has proposed significant limitations on the ability of oncologists to order follow-up positron emission tomography (PET) scans for cancer treatment management and planning.  Prior payment cuts to advanced imaging services, as well as therapeutic radiation, have further pressured integrated community cancer clinics, potentially eroding effective delivery and coordination of integrated care to Medicare seniors.  This is counter to the President's expressed goals for health reform. 

We appreciate and support the President's concern to decrease the costs of health care.  We are working with the Congress on new processes and payment models to further increase the quality and efficiency of cancer care.  However, continuing reductions in payment for cancer drugs and other treatment related services undermine our efforts to ensure and enhance the delivery of quality, accessible, and efficient cancer care.  We have evolved the world's best cancer care delivery system over the last 40 years, but it is now in crisis.  The sequester cut to cancer drugs is accelerating that crisis and certain budget provisions will worsen it further. 

We ask Congress to strengthen the nation's cancer care delivery by interceding to correct an already flawed Medicare payment system and to immediately stop the sequester cut to cancer drugs.  Legislation has already been introduced in the Congress (H.R. 800 and H.R. 1416) that would accomplish those two objectives.  We also ask Congress to stop any administrative actions and reject budget proposals that will jeopardize the delivery of quality, efficient cancer care for seniors and all Americans battling cancer.

[1] Sections 1847A and 1842(o) of the Social Security Act.

[2] OMB M-13-03; Memorandum for the Heads of Executive Departments and Agencies, January 14, 2013, accessed at http://www.whitehouse.gov/sites/default/files/omb/memoranda/2013/m-13-03.pdf

[3] Community Oncology Practice Impact Report; Community Oncology Alliance, March, 2012

[4] Site of Service Cost Differences for Medicare Patients Receiving Chemotherapy. Milliman, October, 2011.

[5] Site of Service Cost Differences for Medicare Patients Receiving Chemotherapy. Milliman, October, 2011.


'/>"/>
SOURCE Community Oncology Alliance
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
2. ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan
3. PQA and CECity Launch Joint Venture to Deliver First National Pharmacy Quality Measurement, Benchmarking and Reporting Platform for Pharmacies and Health Plans
4. Joint Implant Surgeons of Florida Deploys RTLS Patient Work-flow Management Solution to Improve Efficiency and Patient Experience
5. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
6. FRC to Hold Joint News Conference on HHS Mandate at National Religious Broadcasters Convention
7. Kimberly-Clark Introduces Revolutionary CERVICOOL Cooled Radiofrequency System for Cervical Joint Pain
8. Kimberly-Clark Introduces Revolutionary CERVICOOL Cooled Radiofrequencey System for Cervical Joint Pain
9. Preventice and VOX Telehealth introduce patient education solution to improve recovery from joint replacement surgery
10. A Neusoft Medical pretende adquirir ações da joint venture da Philips, a Philips-Neusoft Medical Systems
11. Neusoft Medical intends to acquire equities in Philips-Neusoft Medical Systems joint venture from Philips
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
(Date:12/8/2016)... Australia Glaucoma Surgery Devices Market Outlook ... "Australia Glaucoma Surgery Devices Market Outlook to 2022", ... Surgery Devices market. The report provides value, in ... average prices (USD) within market segement - Glaucoma ... shares and distribution shares data for each of ...
(Date:12/8/2016)... -- The global biosurgery market is expected to grow at ... 2016 to 2021. The market is poised to reach ... in 2016. The market is primarily driven by rising ... and spinal problems, increasing clearance of biosurgery products by ... management. In this report, the biosurgery market ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... Ball at The Pierre Hotel in New York, NY, on December 3rd, to ... dignitaries and physicians attended the annual event, which raised over $1 million - ...
(Date:12/8/2016)... WV (PRWEB) , ... December 08, 2016 , ... ... it will become Quality Insights beginning January 1, 2017. The name change ... its commitment to measuring and improving health care quality. , “We are very ...
(Date:12/8/2016)... ... 08, 2016 , ... ZyDoc , a New York-based ... Data Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” ... comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ ...
(Date:12/8/2016)... ... 2016 , ... With the increasing demand for dental implants, the National Association ... to inform dentists and patients about the safety issues related to dental restorations. According ... the U.S. is projected to reach $6.4 billion in 2018 with more than 30 ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... continuity to its innovative Unified Instance Manager architecture, meeting the needs of ... new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides ...
Breaking Medicine News(10 mins):